Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development

Journal of Immunology

Volumn 191, Issue 2, 2013, Pages 795-809

  Richards, Jack S ^a,b,c,d   Arumugam, Thangavelu U ^e   Reiling, Linda ^a   Healer, Julie ^b   Hodder, Anthony N ^b   Fowkes, Freya J I ^a,c,f   Cross, Nadia ^a   Langer, Christine ^a   Takeo, Satoru ^e   Uboldi, Alex D ^b   Thompson, Jennifer K ^b   Gilson, Paul R ^a   Coppel, Ross L ^c   Siba, Peter M ^g   King, Christopher L ^h   Torii, Motomi ⁱ   Chitnis, Chetan E ^j   Narum, David L ^k   Mueller, Ivo ^a,i   Crabb, Brendan S ^a   Cowman, Alan F ^b,d   Tsuboi, Takafumi ^e   Beeson, James G ^a,b,c   more..

^a BURNET INSTITUTE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e EHIME UNIVERSITY   (Japan)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^k NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; BIOLOGICAL MARKER; IMMUNOGLOBULIN G ANTIBODY; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN; MICRONEME PROTEIN; PARASITE ANTIBODY; PARASITE ANTIGEN; RECOMBINANT PROTEIN; RHOPTRY PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY RESPONSE; ANTIGEN DETECTION; ARTICLE; CELLULAR DISTRIBUTION; CHILD; DISEASE SURVEILLANCE; DRUG RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; PAPUA NEW GUINEA; PARASITE IDENTIFICATION; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TARGETING; RISK REDUCTION; SEROPREVALENCE; VACCINATION; VACCINE PRODUCTION;

ADOLESCENT; ANTIGENS, PROTOZOAN; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MEROZOITES; PARASITEMIA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84880106192     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300778     Document Type: Article

References (70)

1. World Health Organization. 2011. World Malaria Report. World Health Organization, Geneva, Switzerland.
2. Dondorp, A. M., S.Yeung, L.White, C. Nguon, N. P. Day, D. Socheat, and L. von Seidlein. 2010. Artemisinin resistance: current status and scenarios for containment. Nat. Rev. Microbiol. 8: 272-280.
3. Dondorp, A. M., F. Nosten, P. Yi, D. Das, A. P. Phyo, J. Tarning, K. M. Lwin, F. Ariey, W. Hanpithakpong, S. J. Lee, et al. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361: 455-467.
4. Trape, J. F., A. Tall, N. Diagne, O. Ndiath, A. B. Ly, J. Faye, F. Dieye-Ba, C. Roucher, C. Bouganali, A. Badiane, et al. 2011. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect. Dis. 11: 925-932.
5. Richards, J. S., and J. G. Beeson. 2009. The future for blood-stage vaccines against malaria. Immunol. Cell Biol. 87: 377-390.
6. Fowkes, F. J., J. S. Richards, J. A. Simpson, and J. G. Beeson. 2010. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. PLoS Med. 7: e1000218.
7. Cohen, S., I. A. McGREGOR, and S. Carrington. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192: 733-737.
8. Cowman, A. F., and B. S. Crabb. 2006. Invasion of red blood cells by malaria parasites. Cell 124: 755-766. (Pubitemid 43261450)
9. Blackman, M. J., T. J. Scott-Finnigan, S. Shai, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180: 389-393. (Pubitemid 24181090)
10. Persson, K. E., F. J. McCallum, L. Reiling, N. A. Lister, J. Stubbs, A. F. Cowman, K. Marsh, and J. G. Beeson. 2008. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J. Clin. Invest. 118: 342-351.
11. Cohen, S., G. A. Butcher, and R. B. Crandall. 1969. Action of malarial antibody in vitro. Nature 223: 368-371.
12. Jiang, L., D. Gaur, J. Mu, H. Zhou, C. A. Long, and L. H. Miller. 2011. Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine. Proc. Natl. Acad. Sci. USA 108: 7553-7558.
13. Bouharoun-Tayoun, H., P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe. 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172: 1633-1641.
14. Kumaratilake, L. M., A. Ferrante, T. Jaeger, and C. M. Rzepczyk. 1992. Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect. Immun. 60: 3731-3738.
15. Crompton, P. D., M. A. Kayala, B. Traore, K. Kayentao, A. Ongoiba, G. E. Weiss, D. M. Molina, C. R. Burk, M. Waisberg, A. Jasinskas, et al. 2010. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. USA 107: 6958-6963.
16. Osier, F. H., G. Fegan, S. D. Polley, L. Murungi, F. Verra, K. K. Tetteh, B. Lowe, T. Mwangi, P. C. Bull, A. W. Thomas, et al. 2008. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect. Immun. 76: 2240-2248. (Pubitemid 351656161)
17. Greenhouse, B., B. Ho, A. Hubbard, D. Njama-Meya, D. L. Narum, D. E. Lanar, S. Dutta, P. J. Rosenthal, G. Dorsey, and C. C. John. 2011. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J. Infect. Dis. 204: 19-26.
18. Soe, S., M. Theisen, C. Roussilhon, K. S. Aye, and P. Druilhe. 2004. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect. Immun. 72: 247-252. (Pubitemid 38018182)
19. Agak, G. W., P. Bejon, G. Fegan, N. Gicheru, V. Villard, A. V. Kajava, K. Marsh, and G. Corradin. 2008. Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya. Vaccine 26: 1963-1971.
20. Villard, V., G. W. Agak, G. Frank, A. Jafarshad, C. Servis, I. Nébié, S. B. Sirima, I. Felger, M. Arevalo-Herrera, S. Herrera, et al. 2007. Rapid identification of malaria vaccine candidates based on alpha-helical coiled coil protein motif. PLoS ONE 2: e645.
21. Meraldi, V., I. Nebié, A. B. Tiono, D. Diallo, E. Sanogo, M. Theisen, P. Druilhe, G. Corradin, R. Moret, and B. S. Sirima. 2004. Natural antibody response to Plasmodium falciparum Exp-1, MSP-3 and GLURP long synthetic peptides and association with protection. Parasite Immunol. 26: 265-272. (Pubitemid 39576327)
22. Michon, P., J. L. Cole-Tobian, E. Dabod, S. Schoepflin, J. Igu, M. Susapu, N. Tarongka, P. A. Zimmerman, J. C. Reeder, J. G. Beeson, et al. 2007. The risk of malarial infections and disease in Papua New Guinean children. Am. J. Trop. Med. Hyg. 76: 997-1008. (Pubitemid 351837856)
23. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67: 31-40.
24. Tsuboi, T., S. Takeo, T. U. Arumugam, H. Otsuki, and M. Torii. 2010. The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery. Acta Trop. 114: 171-176.
25. Gao, X., K. P. Yeo, S. S. Aw, C. Kuss, J. K. Iyer, S. Genesan, R. Rajamanonmani, J. Lescar, Z. Bozdech, and P. R. Preiser. 2008. Antibodies targeting the PfRH1 binding domain inhibit invasion of Plasmodium falciparum merozoites. PLoS Pathog. 4: e1000104.
26. Rayner, J. C., M. R. Galinski, P. Ingravallo, and J. W. Barnwell. 2000. Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc. Natl. Acad. Sci. USA 97: 9648-9653. (Pubitemid 30650830)
27. Triglia, T., J. Thompson, S. R. Caruana, M. Delorenzi, T. Speed, and A. F. Cowman. 2001. Identification of proteins from Plasmodium falciparum that are homologous to reticulocyte binding proteins in Plasmodium vivax . Infect. Immun. 69: 1084-1092. (Pubitemid 32109576)
28. Gaur, D., S. Singh, S. Singh, L. Jiang, A. Diouf, and L. H. Miller. 2007. Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion. Proc. Natl. Acad. Sci. USA 104: 17789-17794. (Pubitemid 350210913)
29. Rodriguez, M., S. Lustigman, E. Montero, Y. Oksov, and C. A. Lobo. 2008. PfRH5: a novel reticulocyte-binding family homolog of plasmodium falciparum that binds to the erythrocyte, and an investigation of its receptor. PLoS ONE 3: e3300.
30. Baum, J., L. Chen, J. Healer, S. Lopaticki, M. Boyle, T. Triglia, F. Ehlgen, S. A. Ralph, J. G. Beeson, and A. F. Cowman. 2009. Reticulocyte-binding protein homologue 5 - an essential adhesin involved in invasion of human erythrocytes by Plasmodium falciparum. Int. J. Parasitol. 39: 371-380.
31. Thompson, J. K., T. Triglia, M. B. Reed, and A. F. Cowman. 2001. A novel ligand from Plasmodium falciparum that binds to a sialic acid-containing receptor on the surface of human erythrocytes. Mol. Microbiol. 41: 47-58. (Pubitemid 32660982)
32. Gilberger, T. W., J. K. Thompson, T. Triglia, R. T. Good, M. T. Duraisingh, and A. F. Cowman. 2003. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J. Biol. Chem. 278: 14480-14486. (Pubitemid 36800001)
33. Hodder, A. N., P. E. Crewther, and R. F. Anders. 2001. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69: 3286-3294. (Pubitemid 32332227)
34. Sakamoto, H., S. Takeo, A. G. Maier, J. Sattabongkot, A. F. Cowman, and T. Tsuboi. 2012. Antibodies against a Plasmodium falciparum antigen PfMSPDBL1 inhibit merozoite invasion into human erythrocytes. Vaccine 30: 1972-1980.
35. Arumugam, T. U., S. Takeo, T. Yamasaki, A. Thonkukiatkul, K. Miura, H. Otsuki, H. Zhou, C. A. Long, J. Sattabongkot, J. Thompson, et al. 2011. Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect. Immun. 79: 4523-4532.
36. Kocken, C. H., C. Withers-Martinez, M. A. Dubbeld, A. van der Wel, F. Hackett, A. Valderrama, M. J. Blackman, and A. W. Thomas. 2002. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Infect. Immun. 70: 4471-4476. (Pubitemid 34790958)
37. Zhang, Z. G., W. G. Yu, W. S. Qiu, and H. M. Zhao. 2006. Immunogenicity of C-terminus of Plasmodium falciparum merozoite surface protein 1 expressed as a non-glycosylated polypeptide in yeast. Acta Biochim. Biophys. Sin. (Shanghai) 38: 403-409.
38. Sahar, T., K. S. Reddy, M. Bharadwaj, A. K. Pandey, S. Singh, C. E. Chitnis, and D. Gaur. 2011. Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a key adhesive molecule involved in erythrocyte invasion. PLoS ONE 6: e17102.
39. Tham, W. H., D. W. Wilson, L. Reiling, L. Chen, J. G. Beeson, and A. F. Cowman. 2009. Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect. Immun. 77: 2427-2435.
40. Lopaticki, S., A. G. Maier, J. Thompson, D. W. Wilson, W. H. Tham, T. Triglia, A. Gout, T. P. Speed, J. G. Beeson, J. Healer, and A. F. Cowman. 2011. Reticulocyte and erythrocyte binding-like proteins function cooperatively in invasion of human erythrocytes by malaria parasites. Infect. Immun. 79: 1107-1117.
41. Egan, A. F., P. Burghaus, P. Druilhe, A. A. Holder, and E. M. Riley. 1999. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 21: 133-139. (Pubitemid 29118866)
42. Kauth, C. W., U. Woehlbier, M. Kern, Z. Mekonnen, R. Lutz, N. Mücke, J. Langowski, and H. Bujard. 2006. Interactions between merozoite surface proteins 1, 6, and 7 of the malaria parasite Plasmodium falciparum. J. Biol. Chem. 281: 31517-31527. (Pubitemid 46041417)
43. Kennedy, M. C., J. Wang, Y. Zhang, A. P. Miles, F. Chitsaz, A. Saul, C. A. Long, L. H. Miller, and A. W. Stowers. 2002. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70: 6948-6960. (Pubitemid 35387930)
44. Arumanayagam, P., and S. J. San. 1972. Health trends in three Asian countries - Ceylon, Malaysia and Singapore. Int. J. Epidemiol. 1: 101-109.
45. Pandey, K. C., S. Singh, P. Pattnaik, C. R. Pillai, U. Pillai, A. Lynn, S. K. Jain, and C. E. Chitnis. 2002. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Mol. Biochem. Parasitol. 123: 23-33. (Pubitemid 34880088)
46. Narum, D. L., J. D. Haynes, S. Fuhrmann, K. Moch, H. Liang, S. L. Hoffman, and B. K. Sim. 2000. Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids. Infect. Immun. 68: 1964-1966. (Pubitemid 30164824)
47. Crowther, J. R. 2009. The ELISA Guidebook. Humana Press, New York, NY.
48. Richards, J. S., D. I. Stanisic, F. J. Fowkes, L. Tavul, E. Dabod, J. K. Thompson, S. Kumar, C. E. Chitnis, D. L. Narum, P. Michon, et al. 2010. Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Clin. Infect. Dis. 51: e50-e60.
49. Reiling, L., J. S. Richards, F. J. Fowkes, A. E. Barry, T. Triglia, W. Chokejindachai, P. Michon, L. Tavul, P. M. Siba, A. F. Cowman, et al. 2010. Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. J. Immunol. 185: 6157-6167.
50. Stanisic, D. I., J. S. Richards, F. J. McCallum, P. Michon, C. L. King, S. Schoepflin, P. R. Gilson, V. J. Murphy, R. F. Anders, I. Mueller, and J. G. Beeson. 2009. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness. Infect. Immun. 77: 1165-1174.
51. Reiling, L., J. S. Richards, F. J. Fowkes, D. W. Wilson, W. Chokejindachai, A. E. Barry, W. H. Tham, J. Stubbs, C. Langer, J. Donelson, et al. 2012. The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. PLoS ONE 7: e45253.
52. Lin, E., B. Kiniboro, L. Gray, S. Dobbie, L. Robinson, A. Laumaea, S. Schöpflin, D. Stanisic, I. Betuela, M. Blood-Zikursh, et al. 2010. Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children. PLoS ONE 5: e9047.
53. Perneger, T. V. 1998. What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238. (Pubitemid 28171344)
54. ApiLoc. A database of published protein sub-cellular localisation in Apicomplexa. Available at: http://apiloc.biochem.unimelb.edu.au/apiloc/apiloc. Accessed: February 20, 2013.
55. Fowkes, F. J., R. McGready, N. J. Cross, M. Hommel, J. A. Simpson, S. R. Elliott, J. S. Richards, K. Lackovic, J. Viladpai-Nguen, D. Narum, et al. 2012. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J. Infect. Dis. 206: 1612-1621.
56. Baird, J. K. 1995. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today (Regul. Ed.) 11: 105-111.
57. Doolan, D. L., C. Dobaño, and J. K. Baird. 2009. Acquired immunity to malaria. Clin. Microbiol. Rev. 22: 13-36.
58. Bull, P. C., B. S. Lowe, N. Kaleli, F. Njuga, M. Kortok, A. Ross, F. Ndungu, R. W. Snow, and K. Marsh. 2002. Plasmodium falciparum infections are associated with agglutinating antibodies to parasite-infected erythrocyte surface antigens among healthy Kenyan children. J. Infect. Dis. 185: 1688-1691. (Pubitemid 34587537)
59. Ogutu, B. R., O. J. Apollo, D. McKinney, W. Okoth, J. Siangla, F. Dubovsky, K. Tucker, J. N. Waitumbi, C. Diggs, J. Wittes, et al; MSP-1 Malaria Vaccine Working Group. 2009. Blood stage malaria vaccine eliciting high antigenspecific antibody concentrations confers no protection to young children in Western Kenya. PLoS ONE 4: e4708.
60. Thera, M. A., O. K. Doumbo, D. Coulibaly, M. B. Laurens, A. Ouattara, A. K. Kone, A. B. Guindo, K. Traore, I. Traore, B. Kouriba, et al. 2011. A field trial to assess a blood-stage malaria vaccine. N. Engl. J. Med. 365: 1004-1013.
61. Lawrence, G., Q. Q. Cheng, C. Reed, D. Taylor, A. Stowers, N. Cloonan, C. Rzepczyk, A. Smillie, K. Anderson, D. Pombo, et al. 2000. Effect of vaccination with 3 recombinant asexual-stage malaria antigens on initial growth rates of Plasmodium falciparum in non-immune volunteers. Vaccine 18: 1925-1931. (Pubitemid 30122856)
62. Boyle, M. J., D. W. Wilson, and J. G. Beeson. 2013. New approaches to studying Plasmodium falciparum merozoite invasion and insights into invasion biology. Int. J. Parasitol. 43: 1-10.
63. Hill, A. B. 1965. The Environment and Disease: Association or Causation? Proc. R. Soc. Med. 58: 295-300.
64. Douglas, A. D., A. R. Williams, J. J. Illingworth, G. Kamuyu, S. Biswas, A. L. Goodman, D. H. Wyllie, C. Crosnier, K. Miura, G. J. Wright, et al. 2011. The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. Nat Commun 2: 601.
65. Saul, A. 1987. Kinetic constraints on the development of a malaria vaccine. Parasite Immunol. 9: 1-9. (Pubitemid 17026564)
66. Olugbile, S., C. Kulangara, G. Bang, S. Bertholet, E. Suzarte, V. Villard, G. Frank, R. Audran, A. Razaname, I. Nebie, et al. 2009. Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage-associated Plasmodium falciparum protein PFF0165c. Infect. Immun. 77: 5701-5709.
67. Kulangara, C., S. Luedin, O. Dietz, S. Rusch, G. Frank, D. Mueller, M. Moser, A. V. Kajava, G. Corradin, H. P. Beck, and I. Felger. 2012. Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1. PLoS ONE 7: e46112.
68. Wilson, D. W., F. J. Fowkes, P. R. Gilson, S. R. Elliott, L. Tavul, P. Michon, E. Dabod, P. M. Siba, I. Mueller, B. S. Crabb, and J. G. Beeson. 2011. Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans. PLoS ONE 6: e27705.
69. Miura, K., H. Zhou, A. Diouf, S. E. Moretz, M. P. Fay, L. H. Miller, L. B. Martin, M. A. Pierce, R. D. Ellis, G. E. Mullen, and C. A. Long. 2009. Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting Plasmodium falciparum growth, as determined by the in vitro growth inhibition assay. Clin. Vaccine Immunol. 16: 963-968.
70. Drakeley, C., and J. Cook. 2009. Chapter 5. Potential contribution of seroepidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Adv. Parasitol. 69: 299-352.